Chun-Su Lee
Comptroller/Controller/Auditor at NOVMETAPHARMA CO., LTD.
Net worth: 783 902 $ as of 31/07/2023
Profile
Chun-Su Lee is currently working as an Auditor at NovMetaPharma Co., Ltd.
and NovMetaHealth Co. Ltd.
He completed his undergraduate and graduate degrees from Korea University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVMETAPHARMA CO., LTD.
0.44% | 30/06/2023 | 48,860 ( 0.44% ) | 783 902 $ | 31/07/2023 |
Chun-Su Lee active positions
| Companies | Position | Start |
|---|---|---|
| NOVMETAPHARMA CO., LTD. | Comptroller/Controller/Auditor | 31/03/2015 |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Comptroller/Controller/Auditor | 01/12/2018 |
Training of Chun-Su Lee
| Korea University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NOVMETAPHARMA CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Stock Market
- Insiders
- Chun-Su Lee
